{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:13:40Z","timestamp":1791252820979,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jceh.2014.03.045","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T14:15:44Z","timestamp":1402064144000},"page":"S74-S79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"S3","title":["Staging of Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Ajay","family":"Duseja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.03.045_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.045_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3748\/wjg.v8.i3.385","article-title":"The prognostic molecular markers in hepatocellular carcinoma","volume":"8","author":"Qin","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.03.045_bib3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z","article-title":"Clinical features, and prognosis of hepatocellular carcinoma with reference to serum alfa fetoprotein levels. Analysis of 606 patients","volume":"64","author":"Nomura","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.045_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO;2-H","article-title":"Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?","volume":"88","author":"Marsh","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.045_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. An inter observer variability study","volume":"67","author":"Sorensen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2014.03.045_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A\u00a0new prognostic classification for predicting survival in patients with hepatocellular carcinoma","volume":"3","author":"Chevret","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.045_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2014.03.045_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/jhep.2000.16475","article-title":"Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma","volume":"32","author":"Llovet","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.045_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.045_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1440-1746.2007.05075.x","article-title":"Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score","volume":"23","author":"Chung","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.03.045_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1440-1746.2010.06329.x","article-title":"Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population","volume":"26","author":"Chan","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.03.045_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.50.6.749","article-title":"HCC: what's the score?","volume":"50","author":"Shouval","year":"2002","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.03.045_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000173428","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score","volume":"75","author":"Kitai","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2014.03.045_bib14","doi-asserted-by":"crossref","first-page":"818217","DOI":"10.1155\/2011\/818217","article-title":"Comparison of staging systems of hepatocellular carcinoma","volume":"2011","author":"Sirivatanauksorn","year":"2011","journal-title":"HPB Surg"},{"key":"10.1016\/j.jceh.2014.03.045_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/gut.50.6.881","article-title":"Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child Pugh staging systems in a cohort of 257 patients in Toronto","volume":"50","author":"Levy","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2014.03.045_bib16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.045_bib17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.045_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1478-3231.2012.02811.x","article-title":"Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-na\u00efve patients with hepatocellular carcinoma","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.03.045_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1148\/radiology.216.3.r00se24698","article-title":"Extrahepatic metastases of hepatocellular carcinoma","volume":"216","author":"Katyal","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.045_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma","volume":"13","author":"Uka","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.03.045_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2967\/jnumed.106.036673","article-title":"Dual-tracer PET\/CT imaging in evaluation of metastatic hepatocellular carcinoma","volume":"48","author":"Ho","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jceh.2014.03.045_bib22","first-page":"1615","article-title":"Value of (18) F-FDG PET\/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein","volume":"32","author":"Chen","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.jceh.2014.03.045_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cct.2009.08.002","article-title":"Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design","volume":"31","author":"Hsu","year":"2010","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jceh.2014.03.045_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000231886","article-title":"Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India","volume":"77","author":"Paul","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2014.03.045_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2014.03.045_bib26","first-page":"271","article-title":"Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma","volume":"31","author":"Sarma","year":"2010","journal-title":"Trop Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:20Z","timestamp":1760853740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314002229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":26,"alternative-id":["S0973688314002229"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.045","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staging of Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}